Q.Why are transgenic animals particularly valuable for testing the safety of a vaccine before it is used on humans, compared to testing directly on non-transgenic animals?
You're viewing a preview — the full solution, concept, methods & PYQ mapping are locked.
Start your 14-day free trial to unlock the full solution →Testing whether a new vaccine is safe and effective requires exposing a living organism to the actual target pathogen (or a carefully controlled form of it) after vaccination, and observing whether the vaccinated organism is protected without suffering unacceptable side effects. This kind of testing must be carried out in animals first, well before any human clinical trial is considered, precisely to establish a reasonable degree of safety before ever exposing a human volunteer to the vaccine.
The difficulty is that many pathogens that infect and cause disease in humans do not naturally infect other species, including ordinary, non-transgenic mice; a normal mouse's immune system and cellular biology may simply be resistant to that particular pathogen, meaning the pathogen cannot properly establish an infection in that mouse at all. Testing a candidate vaccine in such a naturally resistant animal would not give a meaningful result, because the animal was never actually at risk of the disease that the vaccine is meant to protect against. …
Unlock everything free for 14 days
- Full step-by-step solutions
- Concept-first explanations
- Methods, shortcuts & mistakes
- PYQ mapping + timed mock tests
Full access for 14 days. No credit card required.